Ethyl 5-oxo-2-pyrrolidinecarboxylate for COVID-19

 Ethyl 5-oxo-2-pyrrolidinecarboxylate has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed ethyl 5-oxo-2-pyrrolidinecarboxylate in detail.
Barkat et al., Bidirectional approach of Punica granatum natural compounds: reduction in lung cancer and SARS-CoV-2 propagation, BMC Complementary Medicine and Therapies, doi:10.1186/s12906-024-04738-1